Versant 440 molecular system

The VERSANT 440 molecular system, the next generation bDNA instrument, combines branched DNA (bDNA) chemistry with improved automation to provide an easy-to-use, robust and reliable method for HIV and hepatitis viral load monitoring on a single platform.

Benefits

bDNA technology simplifies testing. Eliminates extraction, reduces possibilities of cross-contamination compared to PCR methods.

The signal amplification method is designed to maximise accuracy while minimising the impact of viral diversity.

Integrated platform processes up to 168 patient samples per run.

Minimal cost by reducing consumables and hazardous waste.

Excellent assay precision and high reproducibility enable accurate detection of changes in viral load.

Branched DNA technology is a clinically reliable technology. On the VERSANT 440 molecular system, bDNA delivers accurate, reliable results while maximizing productivity and minimizing costs. A real workhorse for molecular HIV and Hepatitis testing.

Dimensions: 62 cm H x 152 cm W x 79 cm D Weight: 159 kg Power supply: 200-240 VAC±10%; 50/60 Hz; 600 VA maximum Ambient: 18-30°C; 24-80% relative humidity, non-condensing;

0-2000 m altitude Integrated computer: Windows® XP operating system External UPS system: 200-240 VAC, 1000 VA.